
Clinical trials administering supplemental zzso to terminal cancer patients were conducted at two hospitals in zzso During the period zzso there were 99 patients with terminal cancer at the zzso zzso zzso The average times of survival after the date of designation as terminal were 43 days for 44 zzso patients and 246 days for 55 zzso zzso Three of the zzso patients were still alive, their average survival being zzso days, on April 1, zzso Similar effectiveness of zzso was also observed at the zzso zzso zzso There were 31 patients with terminal cancer during the period zzso The average survival times were 48 days for 19 control patients and 115 days for 6 zzso zzso One of the zzso patients was still alive, his survival being 215 zzso In addition to the increase in survival times, the administration of large doses of zzso seemed to improve the quality of zzso 

